Erratum: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: A phase II study by the GFM (Annals of Hematology DOI: 10.1007/s00277-013-1686-4)

Annals of Hematology

Volumn 92, Issue 5, 2013, Pages 633-

  Kelaidi, C ^a   Beyne Rauzy, O ^a   Braun, T ^a   Sapena, R ^a   Cougoul, P ^a   Ades L ^a   Pillard, F ^a   Lamberto, C ^a   Charniot, J C ^a   Guerci, A ^a   Choufi, B ^a   Stamatoullas, A ^a   Slama, B ^a   De Renzis, B ^a   Ame, S ^a   Damaj, G ^a   Boyer, F ^a   Chaury, M P ^a   Legros, L ^a   Cheze, S ^a   Testu, A ^a   Gyan, E ^a   Bene M C ^a   Rose, C ^a   Dreyfus, F ^a   Fenaux, P ^a   more..

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 84877919619     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1713-5     Document Type: Erratum

References (0)